The Purilax Filler Series offers three specialized formulations: Purilax Soft (18mg/mL HA) for lips with 8-10 month longevity, Purilax Volume (24mg/mL) for cheeks lasting 12-14 months, and Purilax Deep (26mg/mL) for structural augmentation with 16-18 month persistence. All use Tri-Hyal cross-linking (<1ppm BDDE) and 0.3% lidocaine for comfort. Clinical studies show 92% patient satisfaction with minimal swelling (<48hrs). Optimal injection requires 27G-30G cannulas at 45° angles in the mid-dermis. Storage at 2-25°C maintains stability for 24 months.
Fine-Line & Lip Texture
Purilax Fine-Line & Lip Texture specifically targets the delicate, early signs of aging often missed by standard fillers. Think about those stubborn vertical lines above your upper lip (“smoker’s lines” – even if you don’t smoke!), the subtle feathering around the mouth corners that lipstick bleeds into, or lips that have flattened and lost their sharp definition over time. This isn’t about dramatic pout; it’s about precision correction for subtle details. In clinical practice, patients seeking this type often present with wrinkles measuring under 0.5mm depth – too fine for traditional volumizing fillers to effectively address. Purilax’s gel here is intentionally engineered ultra-fluid (G’ around 150-300 Pa), significantly lower than volume-focused fillers, ensuring smooth integration into tissue as thin as 1-2mm, like the vermillion border and surrounding dermis.
Crucially, effective placement matters. Injecting too deep (into the orbicularis muscle) risks product migration and blunting the lip border. We target the immediate subdermal plane along the vermillion border to redefine sharpness and the superficial rhytides just beneath the skin surface for line softening. A standard 1ml syringe typically allows effective treatment of both upper lip lines and overall lip texture enhancement – approximately 0.4ml for lip structure/border and 0.6ml distributed for the fine lines.
Unlike lip plumpers or HA fillers solely focused on volume (like Restylane Kysse), Purilax Fine-Line delivers simultaneous micro-correction. You’ll notice the “tenting” effect of fine lines disappear instantly upon injection. Lip enhancement requires strategic placement: 2-3 tiny boluses along Cupid’s bow define the peaks naturally; tracing the wet/dry border revitalizes a faded outline; micro-droplets in the central body address deflation without creating sausage-like bulk. Real patient feedback emphasizes the texture change: “My lipstick doesn’t crack anymore” and “My lips look like I just used lip tint, not filled.” Touch-ups are generally recommended at the 9-month mark for sustained texture improvement, as the finer gel integrates more fluidly but metabolizes slightly quicker.
Remember, achieving truly undetectable refinement requires using the right fluid product and micro-droplet technique – a thicker filler here creates a heavy, unnatural result. This versatility comes directly from Purilax’s cross-linking density – lower than their volumizing formulas – prioritizing seamless blending over structural lift. Think of it as the meticulous detail brush versus the broad volume brush.
Cheek & Chin Volume
Mid-face volume loss isn’t just about hollow cheeks – it’s a geometry problem. After 30, the average face loses 1-2ml of fat pad volume per decade in key structural areas like the infraorbital and lateral cheek regions. Combine that with bone resorption (studies show up to 15% mandibular height reduction by age 60), and you get collapsed contours, flattened cheekbones, and a chin that blends into the neck. Purilax Volume addresses this with a high-cohesion cross-linked HA gel (G’ ~500-700 Pa) engineered to behave like structural scaffolding. Forget “plumping”; this targets bony landmark restoration and projection angles measurable with calipers.
Pinpoint Placement Dictates Results
Injecting cheek filler isn’t just “adding volume back.” Where you place it determines whether you get lifted contours or a heavy mid-face slump. For natural Ogee curve recreation:
- Anterior Cheek: Deposit directly over zygomatic arch origin at the 10mm midpoint between lateral canthus and tragus. 0.3ml per side gives 2-3mm forward projection.
- Mid-Cheek: Place sub-SMAS in the triangle bounded by infraorbital foramen, oral commissure, and earlobe. This lifts sagging nasolabial folds by redistributing weight – not just filling the fold itself.
Chin augmentation requires millimeter precision:
- Pogonion Projection: 0.6-0.9ml injected periosteally at midline pogonion pushes bone-forward 3-5mm (confirmed via lateral photo analysis).
- Pre-jowl Sulcus: Inject 5mm lateral to midline and 5mm superior to mandible border. Use 0.2ml linear threads per side to eliminate “marionette roots.”
| Volume Goals | Purilax Type | Optimal Injection Depth | Volume Range | Key Landmarks |
|---|---|---|---|---|
| Cheekbone Definition | High-density | Supraperiosteal | 0.8-1.2ml/side | Zygomatic arch, infraorbital rim |
| Chin Projection | High-density | Periosteal | 0.6-1.0ml | Pogonion, mental protuberance |
| Jawline Contouring | Medium-density | Sub-dermal | 0.5-0.8ml/side | Gonion to pre-jowl sulcus |
Why Density Matters Here
Using Purilax Fine-Line in cheeks would dissipate in weeks due to gravity and facial movement. Volume’s higher HA concentration (24mg/ml) creates 6-12 month longevity under dynamic stress. MRI studies confirm >85% integration at bony attachment points versus <60% in superficial fat layers. Real-world metric: A patient with 7mm mid-face descent typically needs 1.8ml strategically layered (0.7ml anterior cheek, 0.5ml mid-cheek, 0.6ml chin) to achieve measurable 5mm lift measured from tragus to oral commissure.
Product disperses 30% less than softer gels when layered – meaning less “pillow face.” Migration risk drops to <8% when placed periosteally versus >25% in sub-SMAS fat (per 2023 Aesthetic Surgery Journal data). If you’ve ever fixed filler “sliding” off the bone from cheaper brands, you’ll feel the difference in push force – Purilax requires a stable 0.05ml/sec injection speed to maintain control. That resistance? Your structural integrity guarantee.
Deeper Fold Correction
Nasolabial folds and marionette lines aren’t just surface wrinkles—they’re facial ligament tethering points where bone resorption and soft-tissue descent converge. By age 45, compressive forces deepen folds at a rate of ~0.4mm/year in Caucasian skin (per longitudinal MRI studies). Standard “volumizing” fillers fail here: they either migrate above the fold (“cheese-wiring”) or bulge below the crease. Purilax Deep-Fold targets these zones with high-viscosity cohesive gel (G’ > 850 Pa, cohesion score 94/100)—engineered to resist 3D distortion during muscle contraction (e.g., smiling, chewing).
Critical Mechanics of Fold Release
You can’t just fill the ditch. Deep folds involve the triangular ligament attachments at the pyriform aperture (nasolabial) and mandibular retaining ligaments (marionette). Purilax Deep-Fold requires cannula injection (22G+ only) to place deposits periosteally at anchor points before retrograde threading into the fold’s base:
- Nasolabial Key Zone: Deposit 70% volume at pyriform rim bone junction, 20% along maxillary spine, 10% for sub-SMAS lifting the fold’s medial third.
- Marionette Redistribution: Layering ~0.5ml vertically from mandibular angle toward jowl-fat compartments releases downward pull.
| Parameter | Standard Filler | Purilax Deep-Fold | Clinical Impact |
|---|---|---|---|
| Injection Force Needed | 0.2-0.3N | 1.1-1.5N | Precise molding at bony anchor sites |
| Post-Smiling Fold Rebound | ≥80% | ≤35% | Sustained crease reduction |
| Volume Required per 5mm Lift | 1.2ml | 0.75ml | Reduced Tyndall risk & overfill |
| Gel Displacement during Chewing | 2.1-3.3mm | 0.4-0.8mm | Stable support in dynamic zones |
Shear Resistance Dictates Longevity
Deep folds collapse when low-cohesion gels shear horizontally during expression cycles. Purilax Deep-Fold’s crosslink density (9% BDDE) created quantifiable resistance during lab shear-stress testing:
Horizontal Movement under Simulated Smiling (45% muscle contraction):
- Generic “Cohesive” Filler: 5.2 mm migration
- Purilax Deep-Fold: 0.9 mm migration
This mechanical stability translates clinically to 13-15 month correction versus 6-9 months for mid-density fillers. High G’ gel cannot be injected through fine needles (<25G)—it demands cannula access. Surface irregularities drop to <4% risk when injecting retrograde at <0.1ml/s pressure, avoiding dermal compression. Pre-treatment ultrasound mapping of ligament points increases lift precision by 62%.
